Capsule Summary Slidesets

Share

Program Content

Activities

  • Lenvatinib/Pembro for HCC
    Phase Ib Study: Lenvatinib + Pembrolizumab in Unresectable Hepatocellular Carcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2018

    Expires: June 06, 2019

  • REACH-2
    REACH-2: Phase III Second-line Ramucirumab vs Placebo in Advanced Hepatocellular Carcinoma With Elevated Baseline AFP Following First-line Sorafenib
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2018

    Expires: June 07, 2019

  • PREOPANC: Neoadjuvant RCT
    PREOPANC: Phase III Study of Preoperative Radiochemotherapy vs Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 11, 2018

    Expires: June 10, 2019

  • Pembro in Gastric/GEJ
    KEYNOTE-061: Phase III Trial of Second-line Pembrolizumab vs Paclitaxel in Previously Treated, Unresectable Gastric or Gastroesophageal Junction Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 12, 2018

    Expires: June 11, 2019

  • Pancreatic Cancer: Adjuvant mFOLFIRINOX
    PRODIGE 24/CCTG PA.6: Phase III Trial of Adjuvant mFOLFIRINOX vs Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 12, 2018

    Expires: June 11, 2019

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Astellas Text

AstraZeneca

Celgene

Eisai

Genentech TEXT Only

Janssen

Merck Oncology

Seagen